Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.
Comprehensive Immunophenotyping of CSF cells in relapsing-remitting multiple sclerosis patients with daclizumb therapy
In vivo time-lapse imaging shows dynamic oligodendrocyte progenitor behavior during zebrafish development.
Klotho Is a Neuroprotective and Cognition-Enhancing Protein.
Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes.
Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.
Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience.
Benzothiazole and stilbene derivatives as promising PET myelin radiotracers for multiple sclerosis.
Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone.
U.S. Patent Office Declares an Interference Between Forward Pharma and Biogen Regarding the Treatment of Multiple Sclerosis With 480 mg Daily Dose of DMF, the Active Ingredient in Tecfidera(R)
Multiple sclerosis in pregnancy.
PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis.
Autoimmunity in visual loss.
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: Electrophysiological evidence.
Interferon beta-1b-induced Sweet's syndrome in a patient with multiple sclerosis.
Role of regulatory b cells in neuroimmunologic disorders.
The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research.
DNA strand breakage by peroxidase-activated mitoxantrone.
ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.
Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound.
Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis.
Interleukin-10 but not transforming growth factor-β1 gene expression is up-regulated by vitamin D treatment in multiple sclerosis patients.
Site-Specific PEGylation Enhances the Pharmacokinetic Properties and Antitumor Activity of Interferon Beta-1b.

Pages